Sepsis is the leading cause of death worldwide according to the World Health Organization, killing 11 million people each year, many of them children, and disabling many more. But while speedy diagnosis and treatment is crucial in combating sepsis, the medical profession has no reliable and speedy test for the condition.
That is about to change, courtesy of a San Francisco-based medtech start-up. Founded in 2013, Cytovale is now in the final stages of clinical trials of a new test for sepsis that generates results in less than 10 minutes.
“My dad was a critical care physician and my wife is an anesthetist, so I’ve grown up around medicine
→ Continue reading at Forbes - Startups